The Smart 401(k) Rollover Option That Almost Everyone Forgets
When It Comes to Data Collection, Which Companies Can You Trust?
Careless Chinese Baggage Handler Really Throws Himself Into His Work
FedEx Earnings Plummet as Consumers Seek Cheaper Options
NYSE: TEVA
Teva Pharmaceutical Industries
of 5
View this photo on glassdoor.com
Teva says looking to build CNS, respiratory, OTC
Teva sees dividends 20%-25% of operating cash flow
Teva: 70% of cost savings achievable in 3yrs, sees $1.5B-$2B in total savings
Teva sees effective tax rate of 20% by 2017 from 13.5% in 2012
Teva sees organic cash flow from operations $4.5B-$5.5B per year until 2017
Teva Pharmaceutical Industries Limited Enters $376 Million Deal for Xenon Pharmaceuticals Inc. Pain Drug
Teva says to discontinue 12 programs in 2013, adding 18 new programs
Teva and Xenon enter into collaborative development license for XEN402
Elsevier Business Intelligence to host a summit
Teva to end collaboration with MediWound, Globes reports
